Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial

S. Kersting*, M-D. Levin, M. Chamuleau, S. M. G. J. Daenen, E. C. Dompeling, J. K. Doorduijn, M. van Gelder, M. Hoogendoorn, J. M. Kerst, M. Nijland, M. R. Nijziel, E. F. M. Posthuma, R. A. P. Raymakers, M. R. Schaafsma, M. H. Silbermann, H. M. van der Straaten, J. H. Veelken, J. M. I. Vos, S. Wittebol, M. H. J. van OersA. P. Kater

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group.
Original languageEnglish
Pages (from-to)68-74
JournalNetherlands Journal of Medicine
Volume74
Issue number2
Publication statusPublished - Feb 2016

Keywords

  • Chronic lymphocytic leukaemia
  • CLL
  • guidelines
  • HOVON

Cite this